BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 31780396)

  • 1. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
    Liu C; Yu Z; Huang S; Zhao Q; Sun Z; Fletcher C; Jiang Y; Zhang D
    EBioMedicine; 2019 Dec; 50():135-143. PubMed ID: 31780396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel seven‑miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients.
    Lu L; Wu Y; Feng M; Xue X; Fan Y
    Mol Med Rep; 2019 Nov; 20(5):4340-4348. PubMed ID: 31545440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
    Wong N; Khwaja SS; Baker CM; Gay HA; Thorstad WL; Daly MD; Lewis JS; Wang X
    Cancer Med; 2016 Jul; 5(7):1619-28. PubMed ID: 27109697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-MicroRNA Prognostic Signature in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma.
    Worakitchanon W; Panvongsa W; Siripoon T; Kitdumrongthum S; Wongpan A; Arsa L; Trachu N; Jinawath N; Chairoungdua A; Ngamphaiboon N
    JCO Precis Oncol; 2023 May; 7():e2300003. PubMed ID: 37163716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
    Zhao X; Cui L
    J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
    Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
    Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma.
    Zhou Z; Wu W; Li J; Liu C; Xiao Z; Lai Q; Qin R; Shen M; Shi S; Kang M
    BMC Cancer; 2021 Apr; 21(1):395. PubMed ID: 33845800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two miRNA prognostic signatures of head and neck squamous cell carcinoma: A bioinformatic analysis based on the TCGA dataset.
    Wu C; Tong L; Wu C; Chen D; Chen J; Li Q; Jia F; Huang Z
    Cancer Med; 2020 Apr; 9(8):2631-2642. PubMed ID: 32064753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
    Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
    PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
    Qi CL; Sheng JF; Huang ML; Zou Y; Wang YP; Wang F; Zeng F; Hua QQ; Chen SM
    Medicine (Baltimore); 2021 Feb; 100(6):e24618. PubMed ID: 33578572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection.
    Hess J; Unger K; Maihoefer C; Schüttrumpf L; Wintergerst L; Heider T; Weber P; Marschner S; Braselmann H; Samaga D; Kuger S; Pflugradt U; Baumeister P; Walch A; Woischke C; Kirchner T; Werner M; Werner K; Baumann M; Budach V; Combs SE; Debus J; Grosu AL; Krause M; Linge A; Rödel C; Stuschke M; Zips D; Zitzelsberger H; Ganswindt U; Henke M; Belka C
    Clin Cancer Res; 2019 Mar; 25(5):1505-1516. PubMed ID: 30171046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Expression and Effection of MicroRNA-499a in High-Tobacco Exposed Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis.
    Gong SQ; Xu M; Xiang ML; Shan YM; Zhang H
    Front Oncol; 2019; 9():678. PubMed ID: 31417866
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma extracellular vesicle microRNA-491-5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma.
    Panvongsa W; Siripoon T; Worakitchanon W; Arsa L; Trachu N; Jinawath N; Ngamphaiboon N; Chairoungdua A
    Cancer Sci; 2021 Oct; 112(10):4257-4269. PubMed ID: 34273216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma.
    Yang X; Zhang Z; Zhang L; Zhou L
    Sci Rep; 2020 Mar; 10(1):4672. PubMed ID: 32170105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel saliva-based microRNA biomarker panel to detect head and neck cancers.
    Salazar C; Nagadia R; Pandit P; Cooper-White J; Banerjee N; Dimitrova N; Coman WB; Punyadeera C
    Cell Oncol (Dordr); 2014 Oct; 37(5):331-8. PubMed ID: 25156495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
    Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
    Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival.
    Xu X; Li M; Hu J; Chen Z; Yu J; Dong Y; Sun C; Han J
    J Cancer Res Ther; 2018; 14(7):1525-1534. PubMed ID: 30589034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiles of miR-29c, miR-200b and miR-375 in tumour and tumour-adjacent tissues of head and neck cancers.
    Hudcova K; Raudenska M; Gumulec J; Binkova H; Horakova Z; Kostrica R; Babula P; Adam V; Masarik M
    Tumour Biol; 2016 Sep; 37(9):12627-12633. PubMed ID: 27440205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma.
    Zhou Z; Liu C; Liu K; Lv M; Li B; Lan Z; Chen W; Kang M
    Technol Cancer Res Treat; 2020; 19():1533033820980110. PubMed ID: 33327871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.